LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 106 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177,713 | -50.0% | 121,165 | +8.4% | 0.00% | – |
| Q2 2023 | $355,439 | +844.4% | 111,773 | +596.4% | 0.00% | – |
| Q1 2023 | $37,635 | -32.5% | 16,049 | 0.0% | 0.00% | – |
| Q4 2022 | $55,770 | -52.3% | 16,049 | 0.0% | 0.00% | – |
| Q3 2022 | $117,000 | +23.2% | 16,049 | +9.7% | 0.00% | – |
| Q2 2022 | $95,000 | +31.9% | 14,626 | +3.1% | 0.00% | – |
| Q1 2022 | $72,000 | +323.5% | 14,187 | +546.0% | 0.00% | – |
| Q4 2021 | $17,000 | -48.5% | 2,196 | 0.0% | 0.00% | – |
| Q3 2021 | $33,000 | +312.5% | 2,196 | +361.3% | 0.00% | – |
| Q2 2021 | $8,000 | – | 476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
| Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
| Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
| MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
| Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
| HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
| SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
| Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |